Ionis to present at upcoming investor conferences

CARLSBAD, Calif., March 21, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present at the following investor conferences: Stifel 2022 Virtual CNS Days on Monday, March 28, 2022 Guggenheim Virtual Genomic Medicines and Rare Disease Day…

Click here to view original post